Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

13.25
Delayed Data
As of Mar 28
 -0.21 / -1.56%
Today’s Change
12.45
Today|||52-Week Range
19.35
-29.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues105.6M120.8M152.7M191.3M
 
 
 
 
 
Cost of Goods Sold70.8M74.5M108.5M133.3M
 
 
 
 
 
Depreciation And Amortization8.5M7.8M15.0M19.3M
 
 
 
 
 
 
Operating ExpensesGross Income26.2M38.6M29.3M38.7M
 
 
 
 
 
General Expenses27.8M31.4M41.9M37.1M
 
 
 
 
 
Research And Development3.2M3.5M4.6M4.8M
 
 
 
 
 
Total Operating Expenses107.1M113.6M165.4M189.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.6M7.2M-12.7M1.7M
 
 
 
 
 
Extraordinary Charge-2.6M-7.1M-3.0M-7.1M
 
 
 
 
 
Interest Expense On Debt7.1M7.1M12.7M13.0M
 
 
 
 
 
Other Expenses-997.0K740.0K-549.0K5.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.3M-6.3M-28.9M-12.5M
 
 
 
 
 
Income Taxes-2.2M-15.0M-5.5M-2.9M
 
 
 
 
 
Net Income-10.1M-21.3M-23.4M-15.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.7M34.9M41.3M42.9M
 
 
 
 
 
Shares To Calculate EPS Diluted34.7M34.9M41.3M42.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.61-$0.57-$0.37
 
 
 
 
 
EPS Diluted-$0.29-$0.61-$0.57-$0.36